Alimera Sciences reported $36.24M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Abbvie ABBV:US $ 63522M 667M
Aerie Pharmaceuticals AERI:US $ 311.68M 77.15M
Alimera Sciences ALIM:US $ 36.24M 6.84M
Applied Genetic Technologies AGTC:US $ 11.36M 2.18M
Bayer BAYN:GR € 36648M 167M
Insmed INSM:US $ 806.66M 225.97M
Novartis NOVN:VX SF 24373M 150M
Ophthotech OPHT:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M